USA Glucose Monitoring Devices Market 2026
The USA Glucose Monitoring Devices Market was valued at in and is anticipated to reach by , at a CAGR of 0.096 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the USA Glucose Monitoring Devices Market.
This report delivers a comprehensive overview of the USA Glucose Monitoring Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding USA Glucose Monitoring Devices Market. The USA Glucose Monitoring Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
USA Glucose Monitoring Devices Market Scope:
By Product Type
This report delivers a comprehensive overview of the USA Glucose Monitoring Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding USA Glucose Monitoring Devices Market. The USA Glucose Monitoring Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the USA Glucose Monitoring Devices Market.
This report delivers a comprehensive overview of the USA Glucose Monitoring Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding USA Glucose Monitoring Devices Market. The USA Glucose Monitoring Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
USA Glucose Monitoring Devices Market Scope:
By Product Type
- Self-Monitoring Glucose Devices
- Continuous Glucose Monitoring Devices
- Type 1 Diabetics
- Type 2 Diabetics
- Others
- Hospitals and diagnostic centers
- Physician Office Laboratory
- Home Care
- Abbott Diabetes Care
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Dexcom
- Medtronic
- Arkray
- Ascensia Diabetes Care
- Agamatrix Inc.
- Bionime Corporation
- Acon(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the USA Glucose Monitoring Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding USA Glucose Monitoring Devices Market. The USA Glucose Monitoring Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market snippet By Application
3.3. Market Snippet by End-User
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing smart-watch based apps to view their glucose data
4.1.1.2. The emergence of needle-free devices
4.1.2. Restraints:
4.1.2.1. High cost of devices
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Self-Monitoring Glucose Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Continuous Glucose Monitoring Devices
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Type 1 Diabetics*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Type 2 Diabetics
8.4. Others
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User Segment
9.2. Hospitals and diagnostic centers *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Physician Office Laboratory
9.4. Home Care
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. COMPANY PROFILES
11.1. Abbott Diabetes Care*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. F. Hoffmann-La Roche AG
11.3. Johnson & Johnson
11.4. Dexcom
11.5. Medtronic
11.6. Arkray
11.7. Ascensia Diabetes Care
11.8. Agamatrix Inc.
11.9. Bionime Corporation
11.10. Acon(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market snippet By Application
3.3. Market Snippet by End-User
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing smart-watch based apps to view their glucose data
4.1.1.2. The emergence of needle-free devices
4.1.2. Restraints:
4.1.2.1. High cost of devices
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Self-Monitoring Glucose Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Continuous Glucose Monitoring Devices
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Type 1 Diabetics*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Type 2 Diabetics
8.4. Others
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User Segment
9.2. Hospitals and diagnostic centers *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Physician Office Laboratory
9.4. Home Care
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. COMPANY PROFILES
11.1. Abbott Diabetes Care*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. F. Hoffmann-La Roche AG
11.3. Johnson & Johnson
11.4. Dexcom
11.5. Medtronic
11.6. Arkray
11.7. Ascensia Diabetes Care
11.8. Agamatrix Inc.
11.9. Bionime Corporation
11.10. Acon(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
